Identification of Forty-Five Novel and Twenty-Three Known NF1 Mutations in Chinese Patients With Neurofibromatosis Type 1

被引:28
作者
Lee, Ming-Jen [1 ,2 ]
Su, Yi-Ning [1 ]
You, Huey-Ling [1 ]
Chiou, Shinn-Chong [1 ]
Lin, Li-Chu [1 ]
Yang, Chih-Chao [2 ]
Lee, Wang-Chao [3 ]
Hwu, Wu-Liang [3 ]
Hsieh, Fon-Jou [4 ]
Stephenson, Dennis A. [5 ]
Yu, Chia-Li [1 ]
机构
[1] Natl Taiwan Univ, Sch Med, Dept Med Genet, Taipei, Taiwan
[2] Natl Taiwan Univ, Sch Med, Dept Neurol, Taipei, Taiwan
[3] Natl Taiwan Univ, Sch Med, Dept Pediat, Taipei, Taiwan
[4] Natl Taiwan Univ, Sch Med, Dept Obstet & Gynecol, Taipei, Taiwan
[5] UCL, Inst Neurol, Dept Mol Neurosci, London, England
关键词
NF1; mutations; DHPLC; LOH; quantitative PCR; Chinese;
D O I
10.1002/humu.9446
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Neurofibromatosis type 1 (NF1), characterized by skin neurofibromas and an excess of cafe-au-lait spots, is due to mutations in the neurofibromin (NF1) gene. Identifying the genetic defect in individuals with the disease represents a significant challenge because the gene is extremely large with a high incidence of sporadic mutations across the entire gene ranging from single nucleotide substitutes to large deletions. In the present study, we have used a combination of techniques (heteroduplex analysis, sequencing, loss of heterozygosity and quantification of gene dosage) to define the genetic defect in 68 individuals from a cohort of 107 NF1 Taiwanese patients of Chinese origin. Fifty-eight were initially identified using heteroduplex analytical techniques and confirmed by sequence analysis. A further five were identified by direct sequence analysis alone. The reminders were shown to carry large deletions in the NF1 gene by demonstrating loss of heterozygosity that was confirmed by gene dosage measurements using quantitative-PCR techniques. Mis-sense, non-sense, frame-shift or splice-site mutations were identified across the entire gene of which the majority (45/68) were novel in nature. The detection rate with the various analytical techniques and the types of mutation detected are consistent with published data involving both individuals and large cohort studies from other ethnic backgrounds. (C) 2006 Wiley-Liss
引用
收藏
页数:10
相关论文
共 30 条
  • [1] Two novel mutations of the NF1 gene in Chinese Han families with type I neurofibromatosis
    Cai, YJ
    Fan, ZP
    Liu, QJ
    Du, J
    Shen, Y
    Wang, SL
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2005, 39 (02) : 125 - 127
  • [2] IDENTIFICATION AND CHARACTERIZATION OF TRANSCRIPTS FROM THE NEUROFIBROMATOSIS-1 REGION - THE SEQUENCE AND GENOMIC STRUCTURE OF EVI2 AND MAPPING OF OTHER TRANSCRIPTS
    CAWTHON, RM
    OCONNELL, P
    BUCHBERG, AM
    VISKOCHIL, D
    WEISS, RB
    CULVER, M
    STEVENS, J
    JENKINS, NA
    COPELAND, NG
    WHITE, R
    [J]. GENOMICS, 1990, 7 (04) : 555 - 565
  • [3] A MAJOR SEGMENT OF THE NEUROFIBROMATOSIS TYPE-1 GENE - CDNA SEQUENCE, GENOMIC STRUCTURE, AND POINT MUTATIONS
    CAWTHON, RM
    WEISS, R
    XU, GF
    VISKOCHIL, D
    CULVER, M
    STEVENS, J
    ROBERTSON, M
    DUNN, D
    GESTELAND, R
    OCONNELL, P
    WHITE, R
    [J]. CELL, 1990, 62 (01) : 193 - 201
  • [4] Effectiveness of real-time quantitative PCR compare to repeat PCR for the diagnosis of Charcot-Marie-Tooth type 1A and hereditary neuropathy with liability to pressure palsies
    Choi, JR
    Lee, WH
    Sunwoo, IN
    Lee, EK
    Lee, CH
    Lim, JB
    [J]. YONSEI MEDICAL JOURNAL, 2005, 46 (03) : 347 - 352
  • [5] NF1 tumor suppressor gene function: Narrowing the GAP
    Cichowski, K
    Jacks, T
    [J]. CELL, 2001, 104 (04) : 593 - 604
  • [6] De LA, 2003, HUM MUTAT, V21, P171
  • [7] Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the CAP-related domain
    Fahsold, R
    Hoffmeyer, S
    Mischung, C
    Gille, C
    Ehlers, C
    Kücükceylan, N
    Abdel-Nour, M
    Gewies, A
    Peters, H
    Kaufmann, D
    Buske, A
    Tinschert, S
    Nürnberg, P
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (03) : 790 - 818
  • [8] Friedman JM, 1999, AM J MED GENET, V89, P1
  • [9] Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO
  • [10] 2-U